Colorectal cancer is a serious health issue. Many people ask if capecitabine is a good choice for treatment. A recent study looked at the cost and benefits of this drug compared to active monitoring. The study focused on patients with stable or responding metastatic colorectal cancer after 16 weeks of initial treatment. Capecitabine is a chemotherapy drug. It is oft...

Metastatic colorectal cancer (mCRC) is a challenge for doctors. It is important to try to keep patients' quality of life while also extending their lives. Doctors also want to avoid harmful side effects. We have several treatments, but choosing the right one can be tricky, especially since different countries have different drugs approved and the best order of treat...